CTCBIO (Oral Drug Delivery Technology) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
CTCBIO (Oral Drug Delivery Technology) General Information
Description
Rights to a novel oral drug delivery technology. The rights concern a technology for the oral delivery of peptides and proteins.
Contact Information
Corporate Office
- Seoul
- South Korea
Corporate Office
- Seoul
- South Korea
CTCBIO (Oral Drug Delivery Technology) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
CTCBIO (Oral Drug Delivery Technology) Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
CTCBIO (Oral Drug Delivery Technology) FAQs
-
Where is CTCBIO (Oral Drug Delivery Technology) headquartered?
CTCBIO (Oral Drug Delivery Technology) is headquartered in Seoul, South Korea.
-
What industry is CTCBIO (Oral Drug Delivery Technology) in?
CTCBIO (Oral Drug Delivery Technology)’s primary industry is Buildings and Property.
-
Is CTCBIO (Oral Drug Delivery Technology) a private or public company?
CTCBIO (Oral Drug Delivery Technology) is a Private company.
-
What is CTCBIO (Oral Drug Delivery Technology)’s current revenue?
The current revenue for CTCBIO (Oral Drug Delivery Technology) is
. -
Who are CTCBIO (Oral Drug Delivery Technology)’s investors?
CTC Bio and Ferring Pharmaceuticals have invested in CTCBIO (Oral Drug Delivery Technology).
-
When was CTCBIO (Oral Drug Delivery Technology) acquired?
CTCBIO (Oral Drug Delivery Technology) was acquired on 23-Feb-2015.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »